603590 康辰藥業
按盤價 
24.800 +2.010 (+8.820%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.563 | 5.027 | 3.491 | 4.960 | 6.316 |
| 總資產報酬率 ROA (%) | 2.060 | 4.176 | 2.987 | 4.135 | 5.269 |
| 投入資產回報率 ROIC (%) | 2.416 | 4.842 | 3.426 | 4.828 | 6.134 | 邊際利潤分析 |
| 銷售毛利率 (%) | 89.535 | 89.017 | 85.444 | 86.940 | 92.673 |
| 營業利潤率 (%) | 24.920 | 15.574 | 16.234 | 23.746 | 25.997 |
| 息稅前利潤/營業總收入 (%) | 24.330 | 12.095 | 14.129 | 20.433 | 19.767 |
| 淨利潤/營業總收入 (%) | 21.550 | 20.388 | 14.295 | 20.677 | 22.674 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.178 | 119.224 | 99.259 | 72.601 | 75.534 |
| 價值變動淨收益/利潤總額(%) | 10.945 | 3.825 | -5.450 | 18.873 | 6.099 |
| 營業外收支淨額/利潤總額(%) | -0.128 | -16.744 | -0.276 | -1.820 | -1.057 | 償債能力分析 |
| 流動比率 (X) | 3.133 | 3.803 | 5.899 | 6.124 | 3.039 |
| 速動比率 (X) | 2.929 | 3.653 | 5.684 | 5.820 | 2.982 |
| 資產負債率 (%) | 12.206 | 11.067 | 6.852 | 7.141 | 18.536 |
| 帶息債務/全部投入資本 (%) | 4.041 | 4.093 | -0.584 | -0.715 | -0.280 |
| 股東權益/帶息債務 (%) | 2,331.432 | 2,304.434 | -16,868.760 | -13,673.838 | -34,575.586 |
| 股東權益/負債合計 (%) | 654.152 | 731.277 | 1,246.789 | 1,199.940 | 438.682 |
| 利息保障倍數 (X) | -43.586 | -9.710 | -6.856 | -7.073 | -3.318 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 119.225 | 105.785 | 106.064 | 90.845 | 86.988 |
| 存貨周轉天數 (天) | 256.262 | 152.229 | 119.869 | 137.797 | 146.421 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
